GAMMA Investing’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.28M Buy
29,091
+2,863
+11% +$231K 0.08% 189
2026
Q1
$2.27M Buy
26,228
+1,223
+5% +$117K 0.11% 166
2025
Q4
$2.4M Buy
25,005
+3,503
+16% +$340K 0.12% 136
2025
Q3
$2.05M Buy
21,502
+3,351
+18% +$308K 0.11% 152
2025
Q2
$1.58M Buy
18,151
+2,269
+14% +$192K 0.1% 177
2025
Q1
$1.43M Buy
15,882
+4,626
+41% +$414K 0.11% 170
2024
Q4
$899K Sell
11,256
-1,768
-14% -$153K 0.08% 233
2024
Q3
$1.17M Buy
13,024
+3,289
+34% +$277K 0.12% 164
2024
Q2
$766K Buy
9,735
+2,760
+40% +$226K 0.1% 172
2024
Q1
$608K Buy
6,975
+1,819
+35% +$155K 0.12% 144
2023
Q4
$451K Buy
+5,156
New +$393K 0.12% 145

Other funds holding MDT

GAMMA Investing's MDT Position: Q2 2026 in Review

GAMMA Investing increased its Medtronic (MDT) stake by 11% in Q2 2026, buying an estimated $231K and bringing the position to 29,091 shares worth $2.28M. The position accounts for 0.08% of the portfolio, ranked #189.

GAMMA Investing first reported a position in MDT in Q4 2023 and has held it in 11 quarters since. The position peaked at $2.4M in Q4 2025. 673 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • GAMMA Investing held 29,091 shares of Medtronic worth $2.28M as of Q2 2026.
  • GAMMA Investing bought 2,863 Medtronic shares in Q2 2026, an estimated $231K.
  • Medtronic made up 0.08% of GAMMA Investing's portfolio in Q2 2026, its #189 holding.
  • GAMMA Investing first reported a position in Medtronic in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Medtronic position peaked at $2.4M in Q4 2025.
  • 673 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.